BNC Wealth Management’s ResMed RMD Stock Holding History

BNC Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-558	Closed	-$96K	–	386
2020 Q3	$96K	Buy	+558	New	+$103K	0.07%	119

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BNC Wealth Management's RMD Position: Q4 2020 in Review

BNC Wealth Management sold out of ResMed (RMD) in Q4 2020, closing a stake of 558 shares — an estimated $96K sold.

BNC Wealth Management first reported a position in RMD in Q3 2020 and held it in 1 quarter. The position peaked at $96K in Q3 2020. 663 funds tracked by Wall St. Rank hold RMD as of Q4 2020.

BNC Wealth Management reported no remaining ResMed position as of Q4 2020 after selling out during the quarter.
BNC Wealth Management sold 558 ResMed shares in Q4 2020, an estimated $96K.
BNC Wealth Management first reported a position in ResMed in Q3 2020 and held it in 1 quarter.
BNC Wealth Management's ResMed position peaked at $96K in Q3 2020.
663 funds tracked by Wall St. Rank held ResMed as of Q4 2020.

Based on BNC Wealth Management's 13F filing for Q4 2020, filed 5 Mar 2021.